130 related articles for article (PubMed ID: 31744350)
41. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone.
Vogl TJ; Basten LM; Nour-Eldin NA; Kaltenbach B; Bodelle B; Wichmann JL; Ackermann H; Naguib NNN
Int J Hyperthermia; 2018 Jun; 34(4):492-500. PubMed ID: 28774210
[TBL] [Abstract][Full Text] [Related]
42. Ultrasound-Guided Percutaneous Microwave Ablation for Solid Benign Thyroid Nodules: Comparison of MWA versus Control Group.
Wu W; Gong X; Zhou Q; Chen X; Chen X
Int J Endocrinol; 2017; 2017():9724090. PubMed ID: 29333159
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of Ablation Therapy for Secondary Hyperparathyroidism by Ultrasound Guided Percutaneous Thermoablation.
Zhao J; Qian L; Zu Y; Wei Y; Hu X
Ultrasound Med Biol; 2016 May; 42(5):1058-65. PubMed ID: 26944529
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease.
Peng C; Zhang Z; Liu J; Chen H; Tu X; Hu R; Ni J; Weng N; Pang H; Xue Z
Head Neck; 2017 Mar; 39(3):564-571. PubMed ID: 28032671
[TBL] [Abstract][Full Text] [Related]
45. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study.
Koc H; Hoser H; Akdag Y; Kendir C; Ersoy FF
Int Urol Nephrol; 2019 Jul; 51(7):1261-1270. PubMed ID: 31161518
[TBL] [Abstract][Full Text] [Related]
46. Feasibility and Efficacy of Microwave Ablation Combined with Iodine-125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience.
Lu M; Yao W; Zhang T; Fan W; Zhong Z; Li J; Zhang F
Oncologist; 2017 Dec; 22(12):1500-1505. PubMed ID: 28701568
[TBL] [Abstract][Full Text] [Related]
47. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study.
Teng D; Ding L; Wang Y; Liu C; Xia Y; Wang H
Endocrine; 2018 Dec; 62(3):648-654. PubMed ID: 30105431
[TBL] [Abstract][Full Text] [Related]
48. Focused, minimally invasive radio-guided parathyroidectomy: a feasible and safe option for elderly patients with primary hyperparathyroidism.
Ben Haim M; Zwas ST; Munz Y; Rosin D; Shabtai EL; Kuriansky J; Olchovsky D; Zmora O; Scarlat A; Ayalon A; Shabtai M
Isr Med Assoc J; 2003 May; 5(5):326-8. PubMed ID: 12811947
[TBL] [Abstract][Full Text] [Related]
49. Efficacy, safety and feasibility of ultrasound-guided percutaneous microwave ablation for large hepatic hemangioma.
Tang XY; Wang Z; Wang T; Cui D; Zhai B
J Dig Dis; 2015 Sep; 16(9):525-30. PubMed ID: 24945806
[TBL] [Abstract][Full Text] [Related]
50. Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas.
Liu F; Yu X; Liang P; Cheng Z; Han Z; Yu J
Int J Hyperthermia; 2018 Nov; 34(7):1061-1066. PubMed ID: 29025295
[TBL] [Abstract][Full Text] [Related]
51. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
[TBL] [Abstract][Full Text] [Related]
52. Tertiary hyperparathyroidism resistant to cinacalcet treatment.
Okada M; Tominaga Y; Izumi K; Nobata H; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Nanmoku K; Watarai T; Uchida K
Ther Apher Dial; 2011 Jun; 15 Suppl 1():33-7. PubMed ID: 21595850
[TBL] [Abstract][Full Text] [Related]
53. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
Zhang L; Yao L; Hua Z; Bian WJ; Li WG
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
[TBL] [Abstract][Full Text] [Related]
54. Ultrasound-guided microwave ablation in the treatment of benign thyroid nodules in 435 patients.
Liu YJ; Qian LX; Liu D; Zhao JF
Exp Biol Med (Maywood); 2017 Sep; 242(15):1515-1523. PubMed ID: 28847173
[TBL] [Abstract][Full Text] [Related]
55. Comparative study evaluating the efficiency of cooled and uncooled single-treatment MWA in thyroid nodules after a 3-month follow up.
Mader OM; Tanha NF; Mader A; Happel C; Korkusuz Y; Grünwald F
Eur J Radiol Open; 2017; 4():4-8. PubMed ID: 28203621
[TBL] [Abstract][Full Text] [Related]
56. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies.
Feng B; Liang P; Cheng Z; Yu X; Yu J; Han Z; Liu F
Eur J Endocrinol; 2012 Jun; 166(6):1031-7. PubMed ID: 22447813
[TBL] [Abstract][Full Text] [Related]
57. US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.
Yue W; Jiang T; Ai Z; Deng E; Chai H; Li X; He H; Zhang Z; Weng N; Qin X; Fan J; Tang X; Heng W; Li Y; Sun L; Peng C; Xu H
Radiology; 2024 Apr; 311(1):e231852. PubMed ID: 38625007
[TBL] [Abstract][Full Text] [Related]
58. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney.
Lin Y; Liang P; Yu XL; Yu J; Cheng ZG; Han ZY; Liu FY
Urology; 2014 Feb; 83(2):357-63. PubMed ID: 24321484
[TBL] [Abstract][Full Text] [Related]
59. Feasibility, safety, and efficacy of ultrasound-guided percutaneous microwave ablation for giant hepatic hemangioma.
Wang Z; Tang X; Qi X; Shi Y; Chi J; Li P; Zhai B
Int J Hyperthermia; 2018; 35(1):246-252. PubMed ID: 30130992
[TBL] [Abstract][Full Text] [Related]
60. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
